Top Five Listed Insurers Report Combined H1 Profit of 317.4 Billion Yuan, Unveiling 39 Billion Yuan in Dividend Payouts

Deep News
08/31

The release of the interim reports for the five major A-share listed insurers in the final week of August has laid the industry's first-half profitability picture bare on the table. Their combined net profits attributable to shareholders reached 317.387 billion yuan, a substantial 78.12% year-on-year surge compared to the 178.193 billion yuan recorded in the same period last year. On a daily average basis for the first six months, these five insurers collectively generated 1.754 billion yuan in profit each day.

While the collective performance hit new highs, the operating results of these five giants each carry distinct characteristics. 中国人寿 emerged as the strongest performer this year, posting a net profit attributable to shareholders of 134.489 billion yuan, a remarkable 228.60% year-on-year increase and its first-ever half-year net profit exceeding the 100 billion yuan mark since listing. Its new business value reached 38.167 billion yuan, up 33.7% year-on-year, maintaining its leading position within the industry. 中国平安 pursued a path of balanced and steady growth, reporting a net profit of 92.585 billion yuan, up 36.10% year-on-year, with its life insurance, P&C insurance, banking, and technology segments advancing in tandem, and new business value for life and health insurance climbing 11.2% to 24.847 billion yuan.

中国人保's core strength remains anchored in its P&C insurance division, with net profit reaching 36.745 billion yuan, a 38.50% increase, while its P&C market share held firm at 33.3%, solidifying its top industry position. Its new business value grew 5.2% on a comparable basis to 5.177 billion yuan, reflecting solid and steady overall growth without significant volatility. In contrast, 中国太保 recorded the lowest net profit growth rate among the five, climbing 10.40% to 30.775 billion yuan, with life insurance new business value up 12.7% to 10.758 billion yuan. This year, however, marked a significant milestone for the company as it introduced its first interim dividend since listing. 新华保险 demonstrated the most pronounced earnings elasticity, with net profit attributable to shareholders soaring 54.00% to 22.793 billion yuan and new business value rising 11.9% to approximately 6.92 billion yuan. With its equity allocation at 25.6%, the company's earnings release tends to be significantly more forceful when market conditions improve.

Many may wonder why insurer profits have surged so dramatically, and the key lies in the investment segment. The first half of the year brought a structural market recovery, with the five insurers' combined investment income reaching 641.33 billion yuan. The bullish bond market propped up the fixed-income asset base, while the A-share market recovery, highlighted by the STAR 50 Index climbing 25.77%, prompted all the companies to increase equity allocations, turning the adage of "seeking returns from equities" into tangible book profits. The new accounting standards further amplified this effect, as changes in fair value are now directly recognized in current-period profits, allowing market rallies to translate directly into financial statements. Breaking down the investment data, 中国人寿 saw total investment income of 314.504 billion yuan, skyrocketing 146.70% year-on-year, with its stock portfolio market value surpassing the trillion yuan mark for the first time and a total investment yield of 5.58%. 中国平安 generated 136.942 billion yuan in investment income, a 42.30% increase, adopting a strategy of anchoring with high-dividend stocks and diversifying into tech stocks for growth, achieving a total investment yield of 2.10%. 中国人保's investment income reached 66.327 billion yuan, up 60.00%, with a total yield of 3.70%, showing a marked improvement in the second quarter alone. 中国太保 reported 66.022 billion yuan in investment income, up 16.10%, at a 2.40% total yield, with its dividend strategy facing some short-term pressure. 新华保险 led the pack with 57.525 billion yuan in investment income, a 27.00% gain and an annualized total investment yield of 6.70%.

Indeed, investment earnings have shouldered the vast majority of profit growth for insurers this cycle. However, the notable divergence in investment yields, with 新华保险 and 中国人寿 delivering stellar results while 平安 and 太保 lagged relatively, also reflects differences in asset allocation structures. With the bumper earnings, shareholders are reaping tangible rewards. All five listed insurers have unveiled interim dividend plans, with total cash payouts proposed at 39.047 billion yuan, setting a new historical high for dividend scale. 太保's interim dividend this time fills a previous gap. In 2025, 平安, 国寿, 人保, and 新华 had all implemented interim dividends totaling approximately 29.336 billion yuan, with only 太保 absent. This year, it has finally caught up, and Chairman Fu Fan has explicitly stated the commitment to further enhance the stability, sustainability, and predictability of dividends. The shift from a single annual dividend to a semiannual cadence is not merely a change in frequency; it signals a substantive transformation in how listed insurers approach shareholder returns.

In conclusion, the high growth in this round of insurer interim reports is largely attributable to the investment income explosion driven by a recovering capital market, rather than an explosive expansion in core insurance operations. While new business value across the companies maintained positive growth, divergence persists. Investment income is highly cyclical, and equity markets cannot sustain a one-way upward trajectory indefinitely. Balancing equity investments with fixed-income allocations while sustaining high dividend standards remains the challenge confronting leading insurers. For investors, it is crucial to recognize the staged earnings recovery in the industry while remaining vigilant about the potential risks arising from capital market volatility.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10